New drug SEP-631 tested in healthy people for safety
Knowledge-focused
Completed
This early-phase study tested the safety and how the body processes a new drug called SEP-631 in 120 healthy adults aged 18 to 60. Participants received either the drug or a placebo to check for side effects and measure drug levels in the blood. The goal was to gather safety info…
Phase: PHASE1 • Sponsor: Septerna, Inc. • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC